Original Research
Accepted on 21 Feb 2025
Global Trends in Tumor-Associated Neutrophil Research: A Bibliometric and Visual Analysis
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2025.1478092
Type at least 3 characters
7,152 articles
Articles
Original Research
Accepted on 21 Feb 2025
Multi-targeted, NOT gated CAR-T cells as a strategy to protect normal lineages for blood cancer therapy
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2025.1493329
Review
Accepted on 21 Feb 2025
Adverse Events Associated with Hepatic Arterial Infusion Chemotherapy and Its Combination Therapies in Hepatocellular Carcinoma: A Systematic Review
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2025.1531249
Original Research
Accepted on 21 Feb 2025
Cancer Immunotherapy by Silencing Transcription Factor c-Rel Using Peptide-Based Nanoparticles
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2025.1554496
Original Research
Accepted on 21 Feb 2025
Huoshan Dendrobium Zengye Jiedu Formula Mitigates Radiation-Induced Oral Mucositis and Improves Oral Immune Microenvironment by Targeting the EGFR/PI3K/AKT Pathway: Evidence from Network Pharmacology, Molecular Docking, and Experimental Validation
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2025.1559400
Original Research
Accepted on 21 Feb 2025
Molecular Characteristics, Cancer Immune of LRP1B and its relationship with Hedgehog Signalling Pathway in Colorectal Cancer
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2025.1567102
Mini Review
Accepted on 21 Feb 2025
Therapeutic Strategies for Adrenocortical Carcinoma: Integrating Genomic Insights, Molecular Targeting, and Immunotherapy
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2025.1545012
Original Research
Accepted on 21 Feb 2025
Entinostat, a Histone Deacetylase Inhibitor, Enhances CAR-NK Cell Anti-Tumor Activity by Sustaining CAR Expression
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2025.1533044
Original Research
Accepted on 21 Feb 2025
Safety and Efficacy of PD-1 inhibitors plus Tyrosine kinase inhibitors Combination Therapy in Patients with Advanced Hepatocellular Carcinoma Combined with Hyperbilirubinemia: A Retrospective Cohort Study
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2025.1530477
Original Research
Accepted on 21 Feb 2025
Hypoxia-Associated Genes as Predictors of Outcomes in Gastric Cancer: A Genomic Approach
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2025.1553477
Original Research
Accepted on 21 Feb 2025
Single-cell and transcriptome analyses revealed CTHRC1 a potential therapeutic target mediating invasion and tumor microenvironment in TNBC: Experimental validation
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2025.1534981
Original Research
Accepted on 21 Feb 2025
Mutated DNA methyltransferase 3 alpha (DNMT3A) creates a public HLA-DQ-binding neoantigen on acute myeloid leukemia
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2025.1556121
Original Research
Published on 21 Feb 2025
Prognostic analysis of esophageal cancer patients after neoadjuvant therapy
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2025.1553086
Correction
Published on 21 Feb 2025
Corrigendum: Anti-Mesothelin CAR-NK cells as a novel targeted therapy against cervical cancer
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2025.1571555
Review
Accepted on 31 Jan 2025
Clinical Evidence of Immunogenicity of CAR-T Cell Therapies and Its Implication in the Clinical Development of CAR-T Drug Products
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2025.1512494
Systematic Review
Accepted on 20 Feb 2025
Effectiveness and safety of ICIs for the treatment of advanced CC: A systematic review and meta-analysis
in Cancer Immunity and Immunotherapy
Frontiers in Immunology
doi 10.3389/fimmu.2025.1542850